+91 9425150513 (Asia)        

Market report search

Results for “Diagnostics”

20 reports match your search. Review the report scope or download a free sample.

Available reports

Explore matching market intelligence

20 results
Syndicated Report ID 13898

Phosphate Buffered Saline Pbs Tablet Market Size, Share & Industry Analysis, By Type (100 mL / 200 mL Preparation Tablets, 500 mL Preparation Tablets, 1,000 mL / Other Formats), By Application (Cell Culture, Immunoassays & ELISA, Molecular Biology, Histology & Diagnostics, Other Laboratory Uses), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs / CDMOs), By Product Formulation (Standard PBS, PBS-Tween, Specialty / Low-Ionic-Strength PBS), By Packaging (Bottle Packs, Blister / Individual Packs, Bulk Laboratory Packs), and Regional Forecast, 2026-2034

Global Phosphate Buffered Saline Tablet market was valued at USD 120 million in 2024 and is projected to reach USD 210 million by 2032, at a CAGR of 7.3%.

05 Oct 2026 129 Pages
View Report Free Sample
Syndicated Report ID 15968

Circulating Tumor Cells And Cancer Stem Cells Market Size, Share & Industry Analysis, By Type (Cell Enrichment, Cell Detection, CTC Analysis), By Application (Clinical Diagnostics, Liquid Biopsy & Monitoring, Research & Development, Prognosis & Therapy Selection), By Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Other Cancers), By Technology (Immunomagnetic Enrichment, Microfluidics, Size/Deformability-Based Isolation, Imaging & Single-Cell Analysis), By End User (Hospitals, Diagnostic Laboratories, Medical Research Institutes, Pharmaceutical & Biotechnology Companies), and Regional Forecast, 2026-2034

Global CTC and CSC market was valued at USD 17.48bn in 2024 and is projected to reach USD 48.93bn by 2031, at a CAGR of 16.2% during the forecast period.

28 Sep 2026 109 Pages
View Report Free Sample
Syndicated Report ID 15615

Head And Neck Cancer Diagnostics Market Size, Share & Industry Analysis, By Type (Biopsy & Blood Tests, Imaging, Endoscopy, Dental Diagnostics), By Application (Oral Cavity & Oropharyngeal Cancer, Laryngeal & Hypopharyngeal Cancer, Nasopharyngeal Cancer, Salivary Gland & Sinonasal Cancer), By End User (Hospitals, Specialty Cancer Clinics, Diagnostic Imaging Centers, Pathology & Molecular Laboratories), By Diagnostic Stage (Initial Detection, Histologic Confirmation, Staging & Treatment Planning, Recurrence / Surveillance), By Technology (Histopathology & IHC, HPV/EBV Molecular Testing, CT/MRI/PET Imaging, Digital Pathology & AI-Assisted Diagnostics), and Regional Forecast, 2026-2034

Head and Neck Cancer Diagnostics market valued at USD 1.85?billion in 2024, projected to reach USD 3.47?billion by 2032, at a CAGR of 7.1% during the forecast period.

28 Sep 2026 78 Pages
View Report Free Sample